WithdrawnPhase 4

The IDEAL-PCI Extended Registry

Stopped: not started due to regulatory reasons

Austria0

Plain-language summary

The purpose of this study is to determine the efficacy and safety of a routine individualized antiplatelet therapy after coronary stent implantation by evaluating "on-treatment" platelet reactivity with Multiple Electrode Aggregometry (MEA, Multiplate® Analyzer). IDEAL-PCI Extended is the continuation of the IDEAL-PCI registry with additional focus on bleeding events and net clinical benefit

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all consecutive PCI patients Exclusion Criteria: * pregnancy

What they're measuring

stent thrombosis

Timeframe: 1 year

bleeding

Timeframe: 1 year

Trial details

NCT IDNCT02974777

SponsorKaiser Franz Josef Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-01

View on ClinicalTrials.gov More Coronary Arterioscleroses trials